Latest news
4Moving Biotech Completes Enrollment in Phase 2a INFLAM MOTION Study Evaluating First-in-class Intra-articular GLP-1 Therapy Targeting Synovitis as a Driver of Pain and Disease Progression in Knee Osteoarthritis - afp.comafp.com · Tue, 04 Aug 2026 11:06:27 GMTVantage Biosciences Completes Enrollment in Phase 2 - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 11:00:00 GMT4MOVING-BIOTECH - The FactsThe Facts · Tue, 04 Aug 2026 05:01:08 GMTArrowhead Pharmaceuticals (ARWR) Completes Enrollment in YOSEMITE Trial - GuruFocusGuruFocus · Mon, 27 Jul 2026 18:00:46 GMT